RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2008; 133(38): 1907-1910
DOI: 10.1055/s-0028-1085575
DOI: 10.1055/s-0028-1085575
Aktuelle Diagnositk und Therapie
Hepatologie
© Georg Thieme Verlag KG Stuttgart · New York
Das hepatozelluläre Karzinom
Hepatocellular carcinoma – diagnosis and treatmentWeitere Informationen
Publikationsverlauf
eingereicht: 29.4.2008
akzeptiert: 10.7.2008
Publikationsdatum:
10. September 2008 (online)
![](https://www.thieme-connect.de/media/dmw/200838/lookinside/thumbnails/10.1055-s-0028-1085575-1.jpg)
Schlüsselwörter
hepatozellulläres Karzinom - Leberzirrhose - Radiofrequenzablation - transarterielle Chemoembolisation
Key words
hepatocellular carcinoma - liver cirrhosis - radiofrequency ablation - transarterial chemoembolisation
Literatur
- 1 Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005; 42 1208-1236
- 2 Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004; 127 S35-50
- 3 Ferlay J, Autier P, Boniol M. et al . Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007; 18 581-592
- 4 Forner A, Vilana R, Ayuso C. et al . Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology. 2008; 47 97-104
- 5 Garrean S, Hering J, Saied A, Helton W S, Espat N J. Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg. 2008; 195 508-520
- 6 Greten F R, Papendorf F, Bleck J S. et al . Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer. 2005; 92 1862-1868
- 7 Greten T F, Blum H E, Manns M P, Geissler M. Therapie des hepatozellulären Karzinoms. Z Gastroenterol. 2006; 44 43-49
- 8 Greten T F, Wedemeyer H, Manns M P. . Prävention Virus-assoziierter Karzinomentstehung: Am Beispiel des hepatozellulären Karzinoms. Deutsches Ärzteblatt. 2006; 103 A-1817
- 9 Greten T F. Molecular therapy for HCC?. Z Gastroenterol. 2006; 44 205-206
- 10 Llovet J M, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003; 362 1907-1917
- 11 Llovet L, Ricci S, Mazzaferro V. et al . Sorafenib improves survival in advanced hepatocellular carcinoma (HCC): Results of a phase III randomized placebo-controlled trial (SHARP trial). J Clin Oncol. 2007; 25 962s
- 12 Mazzaferro V, Regalia E, Doci R. et al . Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996; 334 693-699
- 13 Talwalkar J A, Gores G J. Diagnosis and staging of hepatocellular carcinoma. Gastroenterology. 2004; 127 S126-132
- 14 Varela M, Real M I, Burrel M. et al . Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol. 2007; 46 474-481
- 15 Williams R, White J, Croce M, Dilawari R. Surgical options in the treatment of hepatocellular carcinoma. Am Surg. 2007; 73 658-662; discussion 662 – 653
Prof. Dr. Tim F. Greten
Klinik für Gastroenterologie, Hepatologie
und Endokrinologie, Medizinische Hochschule Hannover
Carl Neuberg Str. 1
30625 Hannover
eMail: greten.tim@mh-hannover.de